FXR Acetylation Is Normally Dynamically Regulated by p300 and SIRT1 but Constitutively Elevated in Metabolic Disease States
Open Access
- 4 November 2009
- journal article
- Published by Elsevier BV in Cell Metabolism
- Vol. 10 (5), 392-404
- https://doi.org/10.1016/j.cmet.2009.09.009
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Bile acid signaling pathways increase stability of Small Heterodimer Partner (SHP) by inhibiting ubiquitin–proteasomal degradationGenes & Development, 2009
- The p300 Acetylase Is Critical for Ligand-activated Farnesoid X Receptor (FXR) Induction of SHPOnline Journal of Public Health Informatics, 2008
- Phosphorylation of Farnesoid X Receptor by Protein Kinase C Promotes Its Transcriptional ActivityMolecular Endocrinology, 2008
- Metabolic adaptations through the PGC‐1α and SIRT1 pathwaysFEBS Letters, 2007
- Sirtuins in Aging and DiseaseCold Spring Harbor Symposia on Quantitative Biology, 2007
- PGC-1α Activates CYP7A1 and Bile Acid BiosynthesisOnline Journal of Public Health Informatics, 2003
- Negative Control of p53 by Sir2α Promotes Cell Survival under StressCell, 2001
- Chemical genomics: Functional analysis of orphan nuclear receptors in the regulation of bile acid metabolismMedicinal Research Reviews, 2001
- Molecular Basis for Feedback Regulation of Bile Acid Synthesis by Nuclear ReceptorsMolecular Cell, 2000
- Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid HomeostasisCell, 2000